Common

American Logistics Achieves HITRUST r2 Certification

Retrieved on: 
Wednesday, June 29, 2022 - 5:00pm

ST. GEORGE, Utah, June 29, 2022 /PRNewswire/ -- American Logistics LLC, a national leader of providing high-quality transportation management for the healthcare industry, today announced their Common Security Framework (CSF) certification with HITRUST – the pinnacle of compliance for organizations that manage Protected Health Information. HITRUST is a non-profit organization formed specifically to create and maintain the CSF, which addresses security, privacy, and regulatory challenges facing organizations today. HITRUST facilitates a comprehensive framework of prescriptive and scalable security controls, including federal and state regulations, standards, and contexts and incorporates a risk-based approach to their rigorous certification process.

Key Points: 
  • HITRUST certification provides optimum confidence, validating American Logistics' institutionalized data protection to ensure both clients' and internal environments remain safe.
  • American Logistics announces their Common Security Framework (CSF) certification with HITRUST.
  • Certification with HITRUST is laborious and intense, and the American Logistics' Information Security Team leader, Tim Vockrodt, articulates why it's worth the effort and why this industry-leading certification is vital.
  • Eugene Fry a certified HITRUST CSF Practitioner with over 40 years of IT experience has worked with American Logistics during certification processes and concluded, "I have been impressed with American Logistics' security program and the maturity of their commitment to information security and thorough preparation for their audits and assessments."

Odyssey Health, Inc. Completes Safety Evaluation of Cohort II for Concussion Drug

Retrieved on: 
Wednesday, June 29, 2022 - 1:30pm

Data from Cohort II indicates that the drug was safe and well-tolerated.

Key Points: 
  • Data from Cohort II indicates that the drug was safe and well-tolerated.
  • Cohort II was unblinded and evaluated by the Safety Review Committee.
  • Cohort II included six healthy human volunteers who received one dose of PRV-002 or placebo followed by evaluations for abnormal responses.
  • After reviewing the data from Cohort II, I have strong confidence that PRV-002 will continue to show safety for this Phase I clinical trial as an option for the treatment of concussion.

Air Pollution and Humidity Are Potent Triggers of Asthma, But Sufferers Credit Symptoms to More Visible Factors

Retrieved on: 
Wednesday, June 29, 2022 - 1:45pm

The new study reveals the top three cities in the U.S. with the most difficult air quality conditions for asthma, as well as other outdoor and indoor air quality triggers of asthma.

Key Points: 
  • The new study reveals the top three cities in the U.S. with the most difficult air quality conditions for asthma, as well as other outdoor and indoor air quality triggers of asthma.
  • The research reveals that Indianapolis, IN; Houston, TX; and Nashville, TN have the highest concentration of particulate matter (PM2.5)and humidity levels.
  • PM2.5 and humidity are two of the most potent, yet relatively lesser known, triggers of asthma symptoms.
  • Asthma Sufferers Overlook Indoor Air Quality; Most Say Their Asthma Symptoms Are Triggered More by Outdoor Air
    Seventy-two percent (72%) of asthma sufferers report that they associate asthma triggers more frequently with outdoor air than indoor air.

XAI Octagon Floating Rate & Alternative Income Term Trust Announces Private Placement of Convertible Preferred Shares and Registered Direct Placement of Common Shares

Retrieved on: 
Wednesday, June 29, 2022 - 12:38am

The Trust expects to receive net proceeds (before expenses) from the sale of the Convertible Preferred Shares of approximately $9.3 million.

Key Points: 
  • The Trust expects to receive net proceeds (before expenses) from the sale of the Convertible Preferred Shares of approximately $9.3 million.
  • The Convertible Preferred Shares will not be listed on any exchange and may not be transferred without the consent of the Trust.
  • The Convertible Preferred Shares were offered directly to the purchasers without a placement agent, underwriter, broker or dealer.
  • The Trust has agreed to sell 1,450,000 Common Shares at a price of $6.90 per Common Share.

Silicon Motion Announces Expiration of Hart-Scott-Rodino Waiting Period for MaxLinear’s Proposed Acquisition of Silicon Motion

Retrieved on: 
Tuesday, June 28, 2022 - 1:00pm

The expiration of the HSR waiting period occurred at 11:59 p.m.

Key Points: 
  • The expiration of the HSR waiting period occurred at 11:59 p.m.
  • SEC filings for Silicon Motion are available on Silicon Motions website at https://www.siliconmotion.com/investor.
  • Once finalized, the FormS-4and the Proxy Statement will be sent or given to the security holders of Silicon Motion and will contain important information about the proposed transaction and related matters.
  • For further information on Silicon Motion, visit us at www.siliconmotion.com .

National Survey Finds 83% of Consumers are Cutting Back on Personal Spending, Travel Due to Inflation  

Retrieved on: 
Tuesday, June 28, 2022 - 1:00pm

According to the survey results, more than 10% (10.5%) reported eliminating all non-essential purchases and more than 70% (71.67%) said they have made at least some changes to personal travel habits.

Key Points: 
  • According to the survey results, more than 10% (10.5%) reported eliminating all non-essential purchases and more than 70% (71.67%) said they have made at least some changes to personal travel habits.
  • When askedwhich price increases on regularly purchased products or services have hurt consumers the most, gasoline, groceries, and clothing were among the most frequently mentioned items.
  • As bankers, its important that we uncover these financial pain points for consumers as it relates to inflation, said Anthony Labozzetta, President and CEO, Provident Bank.
  • On how consumers are saving on personal spending:
    Shopping at discount stores and switching to generic/store brand items.

Quadient Introduces DigtalBOOST: Pre-packaged Digital Solutions for Common Customer Processes and Contracts

Retrieved on: 
Tuesday, June 28, 2022 - 1:00pm

Quadient (Euronext Paris: QDT), a leader in helping businesses create meaningful customer connections through digital and physical channels, announced today the launch of DigitalBOOST , a pre-packaged suite of digital solutions that enables businesses to easily implement digital, self-service customer processes without IT dependency or investment in expensive platforms.

Key Points: 
  • Quadient (Euronext Paris: QDT), a leader in helping businesses create meaningful customer connections through digital and physical channels, announced today the launch of DigitalBOOST , a pre-packaged suite of digital solutions that enables businesses to easily implement digital, self-service customer processes without IT dependency or investment in expensive platforms.
  • Quadients digital transformation experts have converted years of experience and best practices into DigitalBOOST, packaging together Quadient-hosted solutions that quickly transform manually-fulfilled customer processes and contracts into digital ones accessible through company mobile apps, websites and customer portals.
  • DigitalBOOST is a new ecosystem for Quadient that complements our growing and industry-leading suite of cloud software solutions.
  • DigitalBOOST Customer Processes reduce call center volumes by digitalizing the most common customer-facing processes.

VTAMA® (tapinarof) Cream, 1% PSOARING 3 Final Data Published in JAAD

Retrieved on: 
Tuesday, June 28, 2022 - 1:00pm

VTAMA Creams demonstrated combination of efficacy, remittive effect, durability and tolerability make it a strong addition to the psoriasis armamentarium.

Key Points: 
  • VTAMA Creams demonstrated combination of efficacy, remittive effect, durability and tolerability make it a strong addition to the psoriasis armamentarium.
  • Newly published final data in JAAD includes efficacy outcomes, quality of life, safety, and tolerability assessments observed over long-term use of VTAMA (tapinarof) Cream, 1%.
  • The PSOARING 3 LTE study forms part of Dermavants pivotal Phase 3 plaque psoriasis clinical program for VTAMA Cream.
  • On May 24, Dermavant announced that the FDA had approved VTAMA (tapinarof) Cream, 1% for the treatment of adult plaque psoriasis.

Citizens Financial Group, Inc. Announces Key Aspects of 2022 Capital Plan

Retrieved on: 
Monday, June 27, 2022 - 11:07pm

Citizens Financial Group, Inc. (NYSE: CFG or the Company) today announces key aspects of its 2022 Capital Plan (the Plan), which includes increasing the Companys common share repurchase authorization to $1.0 billion.

Key Points: 
  • Citizens Financial Group, Inc. (NYSE: CFG or the Company) today announces key aspects of its 2022 Capital Plan (the Plan), which includes increasing the Companys common share repurchase authorization to $1.0 billion.
  • Citizens has concluded that its proposed capital distributions under the Plan would be consistent with this preliminary SCB requirement over the relevant quarters.
  • Furthermore, Citizens Board of Directors will consider an increase in the Companys quarterly common stock dividend for the third quarter of 2022.
  • Citizens Financial Group, Inc. is one of the nations oldest and largest financial institutions, with $192.1 billion in assets as of March 31, 2022.

Fraser Buchan Disposes of Talmine Resources Ltd. Shares

Retrieved on: 
Monday, June 27, 2022 - 9:27pm

This press release is issued pursuant to National Instrument 62-104 - Take-Over Bids and Issuer Bids and National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider Reporting Issues.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - June 27, 2022) - Fraser Buchan ("Mr. Buchan") announced today that he has disposed of 600,000 Common shares (the "Disposition") of Talmine Resources Ltd. (the "Issuer").
  • Prior to the Disposition, Mr. Buchan held 1,237,800 Common Shares, representing 18.26% of the issued and outstanding Common shares of the Issuer.
  • As a result of the Disposition, Mr. Buchan now holds an aggregate of 637,800 Common shares, representing approximately 2.01% of the issued and outstanding Common shares of the Issuer as at the date hereof.
  • NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
    To view the source version of this press release, please visit https://www.newsfilecorp.com/release/129212